Capgemini Stock: Technical Rebound After a 44% Drop Over the Year, Two Analysts Revise Their Targets
Capgemini shares rose by 1.62% this Tuesday morning to 103.35 euros, after having reached a low of 101.70 euros the previous day. This improvement occurs in a context of significant erosion, with the stock having lost more than 44% over the year and nearly 23% over the last three months. Two major investment banks adjusted their price targets on the stock today.
Major Institutions Revise Forecasts
Two major institutions simultaneously revised their forecasts for Capgemini this Tuesday, February 17. JP Morgan reduced its price target from 155 to 150 euros, while maintaining a neutral recommendation. Meanwhile, Citi lowered its target from 170 to 160 euros, yet still maintains a buy rating on the stock. At the current level of 103.35 euros, JP Morgan's target implies a potential revaluation of about 45%, while Citi's target suggests a gap of nearly 55% compared to the last quoted price. These downward revisions reflect an adjustment of expectations on the prospects of the IT services group, without questioning the thesis of a share price considered significantly lower than the value estimated by the consensus.
Technical Perspective
From a technical standpoint, the stock of the digital consulting and engineering group is significantly below its main moving averages. The price, at 103.35 euros, remains far from the 50-day moving average (136.42 euros) and the 200-day average (134.31 euros), illustrating the magnitude of the correction suffered in recent weeks. The RSI indicator, at 20, is deeply in oversold territory, a level that historically signals an excess of selling pressure that could precede rebound phases. It is in this context that the stock found support near its identified support threshold around 99.74 euros, a technical zone that has so far contained the decline. The most significant resistance lies at 150.85 euros, a considerable gap from current levels. The group's upcoming financial deadlines — including the first quarter revenue release scheduled for April 30 — could be a crucial catalyst for the stock's trajectory.
